One in four people will suffer during their lifetime from a serious mental or neurological disorder such as Major Depressive Disorder (depression), Alzheimer’s Disease, Parkinson’s Disease, Bipolar Disorder or Schizophrenia. Notwithstanding the enormity of the problem, and unlike other conditions, there is no low-cost, non-invasive, and objective way of measuring brain function to facilitate a fast and accurate diagnosis.
“A barrier to effective care is inaccurate assessment. In countries of all income levels, people who are depressed are often not correctly diagnosed, and others who do not have the disorder are too often misdiagnosed.” - WHO 
A person suffering from depression visiting a GP to seek treatment has a 40-50% chance of receiving a correct diagnosis. The absence of an efficient, objective diagnostic technology causes delays in diagnosis that contribute to massive personal, social and economic costs. In Australia alone the annual direct and indirect costs of mental illness has reached more than $60 billion a year.
NeuralDx’s patented EVestGÔ technology is a fast, non-invasive, painless, and objective diagnostic tool for Mental and Neurological Disorders, with demonstrated ability to discriminate between different psychiatric and neurological disorders after a short – less than one hour – test.
NeuralDx represents a highly promising opportunity to be a part of a transformational breakthrough for the diagnosis of Mental and Neurological Disorders. The Company’s patented technology meets an urgent global societal need for an objective diagnostic device to assist with screening, detection, diagnosis and treatment of depression.
Before investing please consider the offer document and the general risk warning.
Tap 'More Info' to get access to free research, all company releases, and bid instantly for shares.
Solar D is a patented Vitamin D Promoting SPF technology which lets through more of the UVB light that our bodies use to produce vitamin D, while still protecting with Broad Spectrum SPF. With 3,000 retail outlets in Australia including Woolworths and Chemist Warehouse, Solar D also white labels its formula to Spain’s largest pharmaceutical company, Almirall.
The Cup Exchange Ltd (TCX) is a scalable, technology-enabled subscription service created to provide a convenient and sustainable alternative to single-use cups, benefitting all stakeholders. TCX combines a purpose-designed physical cup with an IT system, providing a solution for the 1.2 billion cups disposed of each year in Australia alone, with 90% ending up in landfill.
SendGold is a peer-to-peer digital money platform allowing customers to save, send or gift using gold as money. With the long-term buying power of one of history’s most reliable, heavily traded assets, SendGold gives old money systems an upgrade.
Aiming at becoming the world’s first crowd-sourced funded energy retailer for solar households. DC Power Co. intends to reward solar owners with cheaper bills, better feed-in tariffs, genuine guidance on how to get more out of their solar panels.
Aiming to disrupt the $70 billion energy food and drink market, Revvies are an ultrathin mouth strip containing 40 mg of caffeine. Revvies has seen rapid take up by elite athletes and professional sporting teams and is sold in over 475 retail outlets across Australia.